Novo Nordisk Says Ozempic ‘Very Likely’ to Be on 2027 Medicare Negotiation List: Bloomberg
Novo Nordisk (NYSE: NVO), the Danish drugmaker, expects its diabetes drug Ozempic will “very likely” be on the U.S. government’s […]
Healthcare
US Senator Sanders Says Generic Drugmakers Could Offer Ozempic for Under $100/Month
On Tuesday, U.S. Senator Bernie Sanders said he received confirmation from major generic pharmaceutical companies that they could sell copycat
US Senator Sanders Says Generic Drugmakers Could Offer Ozempic for Under $100/Month Read More »
Walgreens (NASDAQ: WBA) to Pay $106.8 Million to Settle US Prescription Billing Fraud Charges
Walgreens Boots Alliance (NASDAQ: WBA) agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for
Eli Lilly (NYSE: LLY) Invests $1.8 Billion to Expand Production of Key Drugs in Ireland
Eli Lilly (NYSE: LLY) is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely
Eli Lilly (NYSE: LLY) Invests $1.8 Billion to Expand Production of Key Drugs in Ireland Read More »
GSK (NYSE: GSK) Advances mRNA Flu Vaccine to Late-Stage Trials
On Thursday, GSK (NYSE: GSK), the British drugmaker, announced positive results from a mid-stage trial of its seasonal influenza vaccine
GSK (NYSE: GSK) Advances mRNA Flu Vaccine to Late-Stage Trials Read More »
Weight-Loss Market to See 16 New Drugs by 2029: Report
The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business
Weight-Loss Market to See 16 New Drugs by 2029: Report Read More »
Teva and Walgreens Settle with Baltimore Ahead of Scheduled Opioid Trial
On Tuesday, Baltimore said that it has settled with Walgreens (NASDAQ: WBA) over claims that the pharmacy operator fueled opioid
Teva and Walgreens Settle with Baltimore Ahead of Scheduled Opioid Trial Read More »
Teva (NYSE: TEVA) Faces EU Antitrust Fine for Disparaging Rival Multiple Sclerosis Medicine: Reuters
BRUSSELS – Teva (NYSE: TEVA), the world’s largest generic drugmaker, will be hit with an EU antitrust fine in the
AstraZeneca (NASDAQ: AZN) Stock Dips on Lung Cancer Drug Trial Setback
AstraZeneca (NASDAQ: AZN) shares fell in the pre-market trading Tuesday after results from the company’s lung cancer trials showed that
AstraZeneca (NASDAQ: AZN) Stock Dips on Lung Cancer Drug Trial Setback Read More »
AstraZeneca Says Lung Cancer Drug Trial Shows No Significant Improvement in Overall Survival
LONDON – Detailed results from one of AstraZeneca’s (NASDAQ: AZN) key lung cancer trials released on Monday showed that its
MBX Biosciences Eyes $482.5M Valuation for US IPO
On Monday, MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic disorders, including obesity, said it was
MBX Biosciences Eyes $482.5M Valuation for US IPO Read More »
Hoth Therapeutics (NASDAQ: HOTH) Stock Skyrockets Following Approval of HT-001 Phase 2a Human Trials
Hoth Therapeutics (NASDAQ: HOTH) stock surged over 80% during intraday trading after securing approval for the first-in-human Phase 2a clinical
China Detains AstraZeneca (NASDAQ: AZN) Employees in Data, Drug-Import Probes: Bloomberg
Police in China have detained five current and former employees of AstraZeneca (NASDAQ: AZN) for questioning about potential illegal activities,
China Detains AstraZeneca (NASDAQ: AZN) Employees in Data, Drug-Import Probes: Bloomberg Read More »
Abbott (NYSE: ABT) Debuts OTC Glucose Monitoring System in the US, Rivals Dexcom
Abbott Laboratories (NYSE: ABT) has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday,
Abbott (NYSE: ABT) Debuts OTC Glucose Monitoring System in the US, Rivals Dexcom Read More »
Fake Ozempic: How Batch Numbers Help Criminal Groups Spread Dangerous Drugs
In December, Drew, a 36-year-old man from San Antonio, Texas, drove over 250 miles (400 km) to Mexico to buy
Fake Ozempic: How Batch Numbers Help Criminal Groups Spread Dangerous Drugs Read More »
US Prescription Drug Prices Remain Twice as High Despite Negotiations, Reuters Finds
The U.S. government’s first-ever negotiated prices for prescription drugs are still on average more than double, and in some cases
US Prescription Drug Prices Remain Twice as High Despite Negotiations, Reuters Finds Read More »
Ozempic Shortage to Persist into Q4 2024, Novo Nordisk Warns
Novo Nordisk (NYSE: NVO) said the shortage of lower strengths of its diabetes drug Ozempic has deteriorated, with intermittent shortages
Ozempic Shortage to Persist into Q4 2024, Novo Nordisk Warns Read More »
Sanofi’s (NASDAQ: SNY) Mixed Fortunes in MS Drug Trials Has Market Focus on Win
Sanofi’s (NASDAQ: SNY) most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials to treat
Sanofi’s (NASDAQ: SNY) Mixed Fortunes in MS Drug Trials Has Market Focus on Win Read More »
FDA Authorizes Novavax (NASDAQ: NVAX) Updated COVID Vaccine Targeting JN.1 Strain
On Friday, the U.S. Food and Drug Administration granted emergency use authorization for an updated version of Novavax’s (NASDAQ: NVAX)
FDA Authorizes Novavax (NASDAQ: NVAX) Updated COVID Vaccine Targeting JN.1 Strain Read More »
FDA Approves Emergent BioSolutions’ (NYSE: EBS) Smallpox Vaccine for High-Risk Mpox Patients
The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions’ (NYSE: EBS) smallpox vaccine for use in people
US FDA Changes Tobacco Sales Regulations: Photo ID Required for Under-30s
The U.S. Food and Drug Administration has mandated more people show photo identification when buying tobacco products, as the health
US FDA Changes Tobacco Sales Regulations: Photo ID Required for Under-30s Read More »
Biden Cap on Drug Costs To Save Over 1 Million US Seniors $1,000+ Annually, Study Finds
WASHINGTON – More than 1 million people in the U.S. will save over $1,000 a year beginning in 2025 when
Biden Cap on Drug Costs To Save Over 1 Million US Seniors $1,000+ Annually, Study Finds Read More »
Delaware Top Court Will Hear Drugmakers’ Appeal To End Zantac Lawsuits
On Tuesday, Delaware’s highest court said it will hear an appeal by GSK and other drugmakers seeking to end more
Delaware Top Court Will Hear Drugmakers’ Appeal To End Zantac Lawsuits Read More »
Eli Lilly (NYSE: LLY) Introduces Vials of Weight-Loss Drug Zepbound Starting at $399 Per Month
On Tuesday, Eli Lilly (NYSE: LLY) said it has begun selling vials of the lowest starter dose of its popular
